TSHA R&D to Revenue
Taysha Gene Therapies Inc · R&D to Revenue
TSHA R&D to Revenue
Latest reported884.10%period ending
TSHA FY R&D/Revenue (0.00% → 884.10%)
Latest values, visible window
High-resolution chart · PNG
TSHA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 884.099% | |
| 792.0437% | |
| 367.4714% | |
| 3,643.8449% | |
| 0% | |
| 0% | |
| 0% |